Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.645
+0.095 (6.13%)
Sep 8, 2025, 4:00 PM - Market closed

Intelligent Bio Solutions Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212017 - 2020
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2017 - 2020
Net Income
-10.57-10.16-10.63-8.31-7.04
Upgrade
Depreciation & Amortization
1.211.210.97--
Upgrade
Asset Writedown & Restructuring Costs
0.22-4.162.6-
Upgrade
Loss (Gain) on Equity Investments
----0.14
Upgrade
Stock-Based Compensation
0.240.230.26--
Upgrade
Provision & Write-off of Bad Debts
00.01---
Upgrade
Other Operating Activities
-0.06-0.16-2.21-0.090.55
Upgrade
Change in Accounts Receivable
-0.16-0.14-0.29--
Upgrade
Change in Inventory
0.140.2-0.35--
Upgrade
Change in Accounts Payable
2.58-0.630.080.24-0.97
Upgrade
Change in Other Net Operating Assets
-3.28-0.140.632.2-3.97
Upgrade
Operating Cash Flow
-9.68-9.57-7.38-3.36-11.3
Upgrade
Capital Expenditures
-0.23-0.22-0.51-0.38-
Upgrade
Cash Acquisitions
---0.19--
Upgrade
Other Investing Activities
----0.5-
Upgrade
Investing Cash Flow
-0.23-0.22-0.69-0.88-
Upgrade
Issuance of Common Stock
4.614.562.55-22.11
Upgrade
Repurchase of Common Stock
---0.01--
Upgrade
Other Financing Activities
---1.33--2
Upgrade
Financing Cash Flow
4.614.561.44-23.4
Upgrade
Foreign Exchange Rate Adjustments
0.03-0-0.06-0.10.04
Upgrade
Net Cash Flow
-5.284.77-6.7-4.3412.15
Upgrade
Free Cash Flow
-9.91-9.79-7.88-3.74-11.3
Upgrade
Free Cash Flow Margin
-324.62%-314.71%-627.15%--570.39%
Upgrade
Free Cash Flow Per Share
-1.88-6.15-94.16-61.18-260.32
Upgrade
Cash Interest Paid
----0.19
Upgrade
Levered Free Cash Flow
-5.8-5.87-3.67-1.56-6.54
Upgrade
Unlevered Free Cash Flow
-5.76-5.76-3.53-1.56-5.85
Upgrade
Change in Working Capital
-0.72-0.70.082.44-4.94
Upgrade
Updated Aug 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q